Abstract
Following HSCT, donor T cells reacting to differences in a recipient’s genetically determined histocompatibility antigens cause acute GVHD (aGVHD). The immunologic targets includes the thymus resulting in the generation of autoreactive T cells, which later lead to autoimmune-like manifestations in chronic GVHD (cGVHD). Well-established manifestations of cGVHD include dermal sclerosis, sicca syndrome, and bronchiolitisobliterans syndrome, as well as eosinophilia and thrombocytopenia. This chapter describes several of the infrequent or rare clinical-pathological autoimmune-like findings associated with cGVHD such as polymyositis, myasthenia gravis, and serositis. Much less common, poorly understood, or controversial are coronary arteritis, retroperitoneal fibrosis associated with elevated IgG4, and lymphocytic cerebritis.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Krenger W, Hollander GA. The thymus in GVHD pathophysiology. Best Pract Res Clin Haematol. 2008;21(2):119–28.
Zeiser R, Blazar BR. Acute graft-versus-host disease – biologic process, prevention, and therapy. N Engl J Med. 2017;377(22):2167–79.
Tsutsumi Y, Kamiishi T, Kikuchi R, Ito S, Matsuoka S, Teshima T. Myasthenia gravis after allogeneic bone marrow transplantation: a case report and literature review. Hematol Oncol Stem Cell Ther. 2017;S1658-3876(17)30052–3.
Jagasia MH, Greinix HT, Arora M, et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. The 2014 diagnosis and staging working group report. Biol Blood Marrow Transplant. 2015;21(3):389–401 e381.
Fukatsu M, Murakami T, Ohkawara H, et al. A possible role of low regulatory T cells in anti-acetylcholine receptor antibody positive myasthenia gravis after bone marrow transplantation. BMC Neurol. 2017;17(1):93.
Horowitz MM, Rowlings PA. An update from the International Bone Marrow Transplant Registry and the Autologous Blood and Marrow Transplant Registry on current activity in hematopoietic stem cell transplantation. Curr Opin Hematol. 1997;4(6):395–400.
Mackey JR, Desai S, Larratt L, Cwik V, Nabholtz JM. Myasthenia gravis in association with allogeneic bone marrow transplantation: clinical observations, therapeutic implications and review of literature. Bone Marrow Transplant. 1997;19(9):939–42.
Kotani A, Takahashi A, Koga H, et al. Myasthenia gravis after allogeneic bone marrow transplantation treated with mycophenolate mofetil monitored by peripheral blood OX40+ CD4+ T cells. Eur J Haematol. 2002;69(5–6):318–20.
Shimoda K, Gondo H, Harada M, et al. Myasthenia gravis after allogeneic bone marrow transplantation. Bone Marrow Transplant. 1994;14(1):155–6.
Sauter A, Bethge W, Vogel U, Horger M. Cervical fascial and muscular involvement in chronic GVHD after Allo-SCT and radiation therapy. Bone Marrow Transplant. 2009;44(7):451–2.
Morimoto Y, Oka S, Tashima M, Hamahata K, Nohgawa M. Chronic GVHD complicated with polymyositis and cardiomyopathy after myeloablative hematopoietic stem cell transplantation. Rinsho Ketsueki. 2015;56(5):485–90.
Oda K, Nakaseko C, Ozawa S, et al. Fasciitis and myositis: an analysis of muscle-related complications caused by chronic GVHD after allo-SCT. Bone Marrow Transplant. 2009;43(2):159–67.
Sakamoto K, Imamura T, Niwa F, et al. Dermatomyositis developed in a recipient of allogeneic BMT; the differentiation of chronic GVHD and autoimmune disease. Bone Marrow Transplant. 2012;47(4):603–4.
Rackley C, Schultz KR, Goldman FD, et al. Cardiac manifestations of graft-versus-host disease. Biol Blood Marrow Transplant. 2005;11(10):773–80.
Gilman AL, Kooy NW, Atkins DL, et al. Complete heart block in association with graft-versus-host disease. Bone Marrow Transplant. 1998;21(1):85–8.
Chan KW, Taylor GP, Shepherd JD, Shepherd WE. Coronary artery disease following bone marrow transplantation. Bone Marrow Transplant. 1989;4(3):327–30.
Prevost D, Taylor G, Sanatani S, Schultz KR. Coronary vessel involvement by chronic graft-versus-host disease presenting as sudden cardiac death. Bone Marrow Transplant. 2004;34(7):655–6.
Cereda M, Trocino G, Pogliani EM, Schiavina R. A case of cardiac localization of graft-versus-host disease after allogenic bone marrow transplantation. Ital Heart J. 2003;4(1):60–3.
Medinger M, Tichelli A, Bucher C, et al. GVHD after allogeneic haematopoietic SCT for AML: angiogenesis, vascular endothelial growth factor and VEGF receptor expression in the BM. Bone Marrow Transplant. 2013;48(5):715–21.
Mir E, Palomo M, Rovira M, et al. Endothelial damage is aggravated in acute GvHD and could predict its development. Bone Marrow Transplant. 2017;52(9):1317–25.
Polchlopek Blasiak K, Simonetta F, Vargas MI, Chalandon Y. Central nervous system graft-versus-host disease (CNS-GvHD) after allogeneic haematopoietic stem cell transplantation. BMJ Case Rep. 2018;2018:bcr-2017–221840.
Kaliyaperumal S, Watkins B, Sharma P, et al. CD8-predominant T-cell CNS infiltration accompanies GVHD in primates and is improved with immunoprophylaxis. Blood. 2014;123(12):1967–9.
Shulman HM, Sullivan KM, Weiden PL, et al. Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. Am J Med. 1980;69(2):204–17.
Seber A, Khan SP, Kersey JH. Unexplained effusions: association with allogeneic bone marrow transplantation and acute or chronic graft-versus-host disease. Bone Marrow Transplant. 1996;17(2):207–11.
J T Leonard, L F Newell, G Meyers, B Hayes-Lattin, J Gajewski, S Heitner, S Nonas, B Allen, A Stentz, R Frires, R T Maziarz, S G Holtan, (2015) Chronic GvHD-associated serositis and pericarditis. Bone Marrow Transplantation 50(8):1098–104
M Gyger, A Rosenberg, A Shamy, A Hercz, S Caplan, I A Sebag, M L Brisson, D C Roy, (2005) Vascular leak syndrome and serositis as an unusual manifestation of chronic graft-versus-host disease in nonmyeloablative transplants. Bone Marrow Transplantation 35(2):201–3
Dicke C, Kertesz A, Henke RP, et al. Retroperitoneal fibrosis as manifestation of chronic GVHD after allogeneic hematopoietic SCT. Bone Marrow Transplant. 2013;48(3):467–8.
Nanda A, Rizzo JD, Vogelsang GB. A case of retroperitoneal fibrosis in a patient following HSCT. Bone Marrow Transplant. 2005;35(11):1125–6.
Lian L, Wang C, Tian JL. IgG4-related retroperitoneal fibrosis: a newly characterized disease. Int J Rheum Dis. 2016;19(11):1049–55.
Ahmad I, Labbé A-C, Chagnon M, Busque L, Cohen S, Kiss T, Lachance S, Roy D-C, Sauvageau G, Roy J. Incidence and prognostic value of eosinophilia in chronic graft-versus-host disease after nonmyeloablative hematopoietic cell transplantation. Biol Blood Marrow Transplant. 2011;17(11):1673–8.
Leonard JT, Newell LF, Meyers G, Hayes-Lattin B, Gajewski J, Heitner S, Nonas S, Allen B, Stentz A, Frires R, Maziarz RT, Holtan SG. Chronic GvHD-associated serositis and pericarditis. Bone Marrow Transplant. 2015;50(8):1098–104.
Gyger M, Rosenberg A, Shamy A, Hercz A, Caplan S, Sebag IA, Brisson ML, Roy DC. Vascular leak syndrome and serositis as an unusual manifestation of chronic graft-versus-host disease in nonmyeloablative transplants. Bone Marrow Transplant. 2005;35(2):201–3.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Yeung, C.C.S., Shulman, H.M. (2019). Manifestations of Chronic GVHD in Other Organ Systems. In: Yeung, C., Shulman, H. (eds) Pathology of Graft vs. Host Disease. Springer, Cham. https://doi.org/10.1007/978-3-319-42099-8_20
Download citation
DOI: https://doi.org/10.1007/978-3-319-42099-8_20
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-42098-1
Online ISBN: 978-3-319-42099-8
eBook Packages: MedicineMedicine (R0)